CALML3 inhibitors are a class of compounds that target and modulate the activity of the protein CALML3, which is a member of the calmodulin family. Calmodulins are ubiquitous calcium-binding proteins found in eukaryotic cells that play a crucial role in signal transduction and the regulation of various cellular processes. CALML3, specifically, is one of the isoforms of calmodulin and is involved in calcium-dependent processes within cells. Its inhibition is of interest in the realm of basic research to elucidate its specific functions and roles in different cellular contexts.
The chemical class of CALML3 inhibitors typically consists of small molecules or peptides designed to disrupt the interaction between CALML3 and its target proteins by binding to specific regions of CALML3. These inhibitors can exert their effects by competing with endogenous ligands for binding to CALML3 or by altering the conformation of the protein, thereby preventing its normal function. In a broader context, CALML3 inhibitors contribute to our understanding of the intricate regulatory mechanisms within cells that rely on calcium signaling pathways. Researchers use these inhibitors as valuable tools to dissect the roles of CALML3 in various cellular processes, including muscle contraction, neurotransmitter release, and gene expression regulation. By selectively inhibiting CALML3, scientists can gain insights into the specific functions of this protein and its contribution to normal physiology and potential implications in disease states.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $153.00 $600.00 | 27 | |
Calmidazolium inhibits CALM3 by blocking calcium binding, preventing CALM3 from activating downstream signaling pathways. | ||||||
CGS 9343B | 109826-27-9 | sc-203883 | 10 mg | $320.00 | ||
CGS 9343B blocks the calcium-binding sites of CALM3, inhibiting its ability to activate downstream signaling pathways. | ||||||
Trifluoperazine Dihydrochloride | 440-17-5 | sc-201498 sc-201498A | 1 g 5 g | $56.00 $99.00 | 9 | |
Trifluoperazine inhibits CALM3 through allosteric binding, disrupting its ability to activate downstream targets. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
Chlorpromazine interferes with CALM3 signaling by binding to its calcium-binding sites, inhibiting downstream effects. | ||||||
Azelnidipine | 123524-52-7 | sc-252395 | 10 mg | $86.00 | ||
Azelnidipine inhibits CALM3 by blocking calcium entry into cells, reducing CALM3 activation due to low intracellular calcium levels. | ||||||